A detailed history of Carnegie Capital Asset Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 133,834 shares of JNJ stock, worth $19.4 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
133,834
Previous 134,271 0.33%
Holding current value
$19.4 Million
Previous $19.6 Million 10.52%
% of portfolio
0.65%
Previous 0.62%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$145.48 - $167.38 $63,574 - $73,145
-437 Reduced 0.33%
133,834 $21.7 Million
Q2 2024

Jul 19, 2024

SELL
$144.38 - $157.78 $3.81 Million - $4.16 Million
-26,383 Reduced 16.42%
134,271 $19.6 Million
Q1 2024

May 03, 2024

SELL
$155.22 - $162.74 $1.25 Million - $1.31 Million
-8,072 Reduced 4.78%
160,654 $25.4 Million
Q4 2023

Jan 29, 2024

SELL
$145.6 - $158.88 $1.33 Million - $1.45 Million
-9,150 Reduced 5.14%
168,726 $26.4 Million
Q3 2023

Oct 10, 2023

SELL
$155.75 - $174.48 $323,960 - $362,918
-2,080 Reduced 1.16%
177,876 $27.7 Million
Q2 2023

Aug 04, 2023

BUY
$154.35 - $166.11 $156,356 - $168,269
1,013 Added 0.57%
179,956 $29.8 Million
Q1 2023

Apr 19, 2023

BUY
$151.05 - $180.26 $513,570 - $612,884
3,400 Added 1.94%
178,943 $27.7 Million
Q4 2022

Jan 23, 2023

BUY
$160.2 - $179.79 $638,877 - $717,002
3,988 Added 2.32%
175,543 $0
Q3 2022

Oct 13, 2022

BUY
$161.33 - $179.52 $1.07 Million - $1.2 Million
6,658 Added 4.04%
171,555 $28 Million
Q2 2022

Aug 02, 2022

BUY
$168.19 - $186.01 $3.07 Million - $3.39 Million
18,251 Added 12.45%
164,897 $29.3 Million
Q2 2022

Jul 13, 2022

SELL
$168.19 - $186.01 $2.98 Million - $3.29 Million
-17,694 Reduced 10.77%
146,646 $24.2 Million
Q1 2022

Apr 11, 2022

BUY
$158.14 - $179.59 $365,461 - $415,032
2,311 Added 1.43%
164,340 $29.1 Million
Q4 2021

Jan 21, 2022

BUY
$155.93 - $173.01 $1.98 Million - $2.19 Million
12,676 Added 8.49%
162,029 $27.7 Million
Q3 2021

Oct 08, 2021

BUY
$161.5 - $179.47 $437,180 - $485,825
2,707 Added 1.85%
149,353 $24.1 Million
Q2 2021

Jul 16, 2021

BUY
$159.48 - $171.07 $759,124 - $814,293
4,760 Added 3.35%
146,646 $24.2 Million
Q1 2021

Apr 12, 2021

BUY
$153.07 - $170.48 $662,640 - $738,007
4,329 Added 3.15%
141,886 $23.3 Million
Q4 2020

Feb 08, 2021

BUY
$137.11 - $157.38 $290,810 - $333,802
2,121 Added 1.57%
137,557 $21.6 Million
Q3 2020

Oct 13, 2020

BUY
$140.38 - $153.83 $311,362 - $341,194
2,218 Added 1.66%
135,436 $20.2 Million
Q2 2020

Jul 09, 2020

SELL
$128.81 - $155.51 $572,946 - $691,708
-4,448 Reduced 3.23%
133,218 $18.7 Million
Q1 2020

May 08, 2020

SELL
$111.14 - $153.99 $184,158 - $255,161
-1,657 Reduced 1.19%
137,666 $18.1 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $285,600 - $328,025
-2,240 Reduced 1.58%
139,323 $20.3 Million
Q3 2019

Nov 20, 2019

SELL
$126.95 - $142.14 $1.97 Million - $2.21 Million
-15,517 Reduced 9.88%
141,563 $18.3 Million
Q2 2019

Jul 24, 2019

SELL
$131.15 - $144.24 $16,787 - $18,462
-128 Reduced 0.08%
157,080 $21.9 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $3.07 Million - $3.41 Million
24,420 Added 18.39%
157,208 $22 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $595,528 - $716,728
-4,848 Reduced 3.52%
132,788 $17.1 Million
Q3 2018

Nov 27, 2018

SELL
$121.58 - $142.88 $179,816 - $211,319
-1,479 Reduced 1.06%
137,636 $20.1 Million
Q2 2018

Aug 16, 2018

BUY
$119.4 - $131.76 $1.14 Million - $1.26 Million
9,570 Added 7.39%
139,115 $17.9 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $2.1 Million - $2.49 Million
16,776 Added 14.88%
129,545 $16.5 Million
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $1.58 Million - $1.73 Million
12,025 Added 11.94%
112,769 $14.8 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $14,241 - $14,891
110 Added 0.11%
100,744 $14.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
100,634
100,634 $13.3 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Carnegie Capital Asset Management, LLC Portfolio

Follow Carnegie Capital Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.